Detection of Acute Hepatitis B
To detect acute hepatitis B infection, test for HBsAg (hepatitis B surface antigen) using a highly sensitive assay, and confirm with IgM anti-HBc (IgM antibody to hepatitis B core antigen) to distinguish acute from chronic infection 1, 2.
Primary Diagnostic Approach
The detection algorithm follows this sequence:
Initial Screening
- HBsAg testing is the cornerstone of acute hepatitis B detection, as it becomes positive early in infection when the virus infects hepatocytes and secretes large amounts of surface antigen into the bloodstream 1, 3.
- Use highly sensitive enzyme immunoassays with a limit of detection <0.05 IU/ml 1.
- HBsAg detects approximately 95-96% of acute cases when obtained early in the illness 3, 4.
Confirmatory Testing for Acute vs. Chronic Differentiation
- IgM anti-HBc is essential to confirm acute infection and distinguish it from chronic hepatitis B with acute exacerbation 5, 2.
- In acute hepatitis B, IgM anti-HBc appears in high titers and typically disappears within 2 years in 79% of patients who clear the infection 5.
- In chronic hepatitis B patients, IgM anti-HBc persists at lower levels or reappears during flares 5, 6.
Clinical Context and Presentation
Acute hepatitis B typically presents with:
- Gastrointestinal symptoms and jaundice
- Elevated transaminase levels (ALT)
- Presence of both HBsAg and IgM anti-HBc 2
Important Caveats and Pitfalls
The Pre-HBsAg Window Period
- During very early acute infection, HBsAg levels may fall below detection threshold, creating a window where HBV DNA is positive but HBsAg is not detectable, potentially lasting weeks 1.
- In this scenario, IgM anti-HBc becomes particularly valuable, as it can detect acute infection even when HBsAg is negative 5.
- Among HBsAg-negative patients with acute hepatitis, IgM anti-HBc identified 13 patients with histologically confirmed hepatitis B who later developed anti-HBs and/or anti-HBe 5.
Distinguishing Acute from Chronic Flare
Additional parameters that support acute (rather than chronic) infection include 7:
- HBV-DNA negative on admission
- When ALT <400 IU/L, HBV-DNA becomes negative or HBsAg clears or HBeAg/anti-HBe seroconversion occurs
- Lower levels of free anti-HBe and immune complexes compared to chronic infection 6
Comprehensive Screening Panel
For complete initial assessment, the 2025 EASL guidelines recommend 1:
- HBsAg (primary marker)
- Anti-HBc (total antibody to core antigen)
For suspected acute infection specifically, add:
- IgM anti-HBc (to confirm acute infection)
- HBV DNA (viral load, particularly useful in window period)
- ALT levels (assess hepatocellular injury)
More than 95% of adults clear acute hepatitis B spontaneously, making accurate diagnosis critical for appropriate monitoring rather than unnecessary chronic disease management 2.